USANA Health Sciences, Inc. (USNA)

NYSE: USNA · Real-Time Price · USD

14.43

-0.13 (-0.89%)

At close: Sep 3, 2026, 4:00 PM EDT

14.43

0.00 (0.00%)

After-hours: Sep 3, 2026, 4:20 PM EDT

USANA Health Sciences Balance Sheet

Financials in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 4, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Cash & Equivalents	168.56	158.38	181.77	330.42	288.42	239.83
Cash & Short-Term Investments	168.56	158.38	181.77	330.42	288.42	239.83
Cash Growth	11.38%	-12.87%	-44.99%	14.56%	20.26%	-23.11%
Other Receivables	-	9.11	8.22	7.2	7.21	7.16
Receivables	3.34	9.11	8.22	7.2	7.21	7.16
Inventory	86.34	102.61	69.74	61.45	67.09	98.32
Prepaid Expenses	22.83	12.55	13.76	11.39	11.38	13.85
Other Current Assets	-	5.77	5.7	7.28	10.28	5.95
Total Current Assets	281.07	288.41	279.19	417.75	384.38	365.12
Property, Plant & Equipment	94.27	111.54	111.12	107.68	111.69	120.07
Long-Term Investments	20	20	-	-	-	-
Goodwill	109.14	137.96	144.17	17.1	17.37	17.67
Other Intangible Assets	124.62	133.15	151.82	29.92	32.43	30.44
Long-Term Deferred Tax Assets	29.54	27.21	19.64	13.28	9.8	4.84
Other Long-Term Assets	44.58	24.65	42.25	47.03	40.88	39.6
Total Assets	703.21	742.92	748.19	632.76	596.55	577.74

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 4, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Accounts Payable	15.43	17.26	11.98	10.07	11.05	13.51
Accrued Expenses	-	75.41	79.57	80.84	84.26	97.63
Short-Term Debt	-	14	23	0.79	-	-
Current Portion of Leases	-	5.65	6.01	7.28	6.89	7.08
Current Income Taxes Payable	-	3.37	3.71	3.3	4.97	5.19
Current Unearned Revenue	10.09	10.64	12.05	13.91	20.88	19.64
Other Current Liabilities	80.15	2.24	3.3	2.66	15.79	17.75
Total Current Liabilities	105.68	128.57	139.63	118.85	143.83	160.79
Long-Term Leases	-	12.31	10.19	5.14	7.68	10.22
Long-Term Deferred Tax Liabilities	4.66	4.89	4.07	4.55	4.07	7.5
Other Long-Term Liabilities	21.9	10.88	7.97	7.02	6.49	4.11
Total Liabilities	132.24	156.64	161.86	135.56	162.08	182.62

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 4, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	88.11	83.54	75.82	65.66	55.6	50.01
Retained Earnings	451.85	465.72	478.94	445.22	391.64	344.64
Comprehensive Income & Other	-13.68	-16.18	-22.67	-13.7	-12.79	0.46
Total Common Equity	526.31	533.1	532.11	497.2	434.47	395.12
Minority Interest	44.67	53.17	54.22	-	-	-
Shareholders' Equity	570.97	586.27	586.33	497.2	434.47	395.12
Total Liabilities & Equity	703.21	742.92	748.19	632.76	596.55	577.74

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 4, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Total Debt	-	31.96	39.2	13.21	14.57	17.3
Net Cash (Debt)	168.56	126.42	142.56	317.22	273.85	222.54
Net Cash Growth	11.38%	-11.32%	-55.06%	15.84%	23.06%	-23.38%
Net Cash Per Share	9.18	6.81	7.44	16.40	14.18	10.94
Filing Date Shares Outstanding	18.48	18.46	18.9	19.24	19.29	19.32
Total Common Shares Outstanding	18.46	18.28	19.06	19.13	19.21	19.39
Working Capital	175.39	159.84	139.56	298.9	240.55	204.33
Book Value Per Share	28.51	29.16	27.91	25.99	22.62	20.37
Tangible Book Value	292.55	261.99	236.12	450.18	384.67	347.01
Tangible Book Value Per Share	15.85	14.33	12.39	23.53	20.03	17.89
Land	-	6.65	6.36	6.72	6.72	6.99
Buildings	-	78.59	76.68	77.8	78.07	80.82
Machinery	-	123.82	121.16	116.82	113.99	111.47
Leasehold Improvements	-	10.84	12.61	14.34	14.39	15.21

SEC Filings: 10-K · 10-Q